Mental health, 12.5% of the MCQ exam

Substance use disorders

Alcohol, tobacco, vaping, opioids, methamphetamine and cannabis, including withdrawal and harm reduction.

High-yield points

  • NHMRC alcohol guidelines: no more than 10 standard drinks a week and no more than 4 on any one day; a standard drink is 10 g of alcohol.

  • Screen with AUDIT or AUDIT-C; use brief interventions in primary care.

  • Alcohol withdrawal: monitor with a withdrawal scale; diazepam for symptoms; give thiamine before glucose to prevent Wernicke encephalopathy.

  • Wernicke's triad: confusion, ataxia, ophthalmoplegia (often incomplete); treat with high-dose IV thiamine.

  • Opioid dependence: opioid agonist treatment with methadone or buprenorphine (including long-acting injectable buprenorphine).

  • Take-home naloxone is free without a prescription for anyone at risk of or likely to witness an overdose.

  • Smoking cessation: combination NRT or varenicline plus behavioural support (Quitline 13 7848).

India vs Australia

Where the answer the AMC marks correct differs from what’s usually taught in Indian MBBS.

  • Alcohol advice

    India (MBBS)

    General advice to cut down.

    Australia (AMC): what the exam expects

    NHMRC: no more than 10 standard drinks a week and 4 in a day. A standard drink is 10 g alcohol.

  • Tobacco and vaping

    India (MBBS)

    Smokeless tobacco and bidis are major concerns; e-cigarettes are banned.

    Australia (AMC): what the exam expects

    Nicotine vapes are regulated medicines sold through pharmacies. Varenicline and NRT are PBS-subsidised; Quitline 13 7848.

  • Harm reduction

    India (MBBS)

    Needle exchange and OST through NACO programs.

    Australia (AMC): what the exam expects

    Mainstream: needle and syringe programs, supervised injecting in Sydney and Melbourne, free take-home naloxone.

  • Opioid dependence

    India (MBBS)

    Buprenorphine-based OST; methadone limited.

    Australia (AMC): what the exam expects

    Methadone or buprenorphine (including long-acting injectables), often prescribed in general practice.

The Australian context

Nicotine vapes are regulated as medicines in Australia and are only legally sold through pharmacies; recreational vaping products are banned. Harm reduction (needle and syringe programs, supervised injecting facilities in Sydney and Melbourne) is mainstream health policy.